Human-derived 3D cell-based models are more representative of in vivo cellular physiology and have improved longevity in vitro.
In this presentation, we focus on:
- Causes of drug failure in drug development
- The advances in high content screening
- Developments in 3D cell-based models including organ-specific cellular models
- The prediction of tissue specific toxicities such as hepatotoxicity (DILI), cardiotoxicity, nephrotoxicity and neurotoxicity
View the presentation to learn more!
